文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

套囊漏气试验结果与再插管风险的关联:一项回顾性分析

Association Between Cuff Leak Test Results and Reintubation Risk: A Retrospective Analysis.
PubMed 文献 · Shock · 2025-07-08
一句话结论在ICU机械通气≥24小时成人中,套囊漏气量<110 mL或<潮气量15%与48小时内再插管风险独立相关(校正OR 2.86),联合临床危险因素可提高预测准确性。

这项单中心回顾性描述性研究分析了2020年1月至2024年12月收入内科和外科ICU、机械通气≥24小时的742例成人患者,主要结局为计划拔管后48小时内再插管。68例(9.2%)发生再插管;套囊漏气量<110 mL或<潮气量15%者再插管率显著更高(18.7% vs 7.1%,P<0.001)。校正混杂因素后,套囊漏气试验阳性(定义为漏气量<110 mL)仍为再插管的独立预测因素(校正OR 2.86,95%CI 1.65-4.97,P<0.001);延长插管(>7天)、女性、BMI>30 kg/m²、创伤性或困难插管亦为独立预测因素。将套囊漏气试验与这些临床危险因素联合,预测准确性提高(AUC 0.82,95%CI 0.76-0.87)。作者认为套囊漏气试验应纳入拔管决策,尤其对于存在额外拔管后气道并发症危险因素的患者。

要点

  • 742例机械通气≥24小时成人中,套囊漏气量<110 mL或<潮气量15%者48小时内再插管率为18.7%,显著高于漏气量达标者的7.1%(P<0.001)。
  • 校正混杂因素后,套囊漏气试验阳性(漏气量<110 mL)与再插管独立相关(校正OR 2.86,95%CI 1.65-4.97,P<0.001)。
  • 其他独立预测因素包括插管>7天、女性、BMI>30 kg/m²、创伤性或困难插管。
  • 套囊漏气试验联合上述临床危险因素可将预测再插管的AUC提高至0.82(95%CI 0.76-0.87)。
  • 作者认为套囊漏气试验应纳入拔管决策,尤其对存在额外拔管后气道并发症危险因素的患者。

适用人群与场景

  • 2020年1月至2024年12月收入内科和外科ICU、机械通气≥24小时的成人患者,共742例。

诊断标准与关键阈值

  • 套囊漏气试验阳性定义为套囊漏气量<110 mL;原文亦报告漏气量<潮气量15%与再插管率升高相关。

研究设计与关键结果

  • 单中心回顾性描述性研究,纳入742例机械通气≥24小时成人,主要结局为计划拔管后48小时内再插管。
  • 68例(9.2%)发生再插管;套囊漏气量<110 mL或<潮气量15%者再插管率18.7% vs 7.1%(P<0.001)。
  • 校正混杂因素后,套囊漏气试验阳性(漏气量<110 mL)与再插管独立相关(校正OR 2.86,95%CI 1.65-4.97,P<0.001)。
  • 其他独立预测因素包括插管>7天、女性、BMI>30 kg/m²、创伤性或困难插管。
  • 套囊漏气试验联合临床危险因素预测再插管的AUC为0.82(95%CI 0.76-0.87)。

证据类型、等级与局限

  • 证据类型:单中心回顾性描述性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为套囊漏气试验应纳入拔管决策,尤其对存在额外拔管后气道并发症危险因素的患者。
  • 套囊漏气试验联合临床危险因素(插管>7天、女性、BMI>30 kg/m²、创伤性或困难插管)可提高再插管预测准确性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Postextubation airway obstruction represents a significant complication in critical care, potentially necessitating reintubation and prolonging intensive care unit (ICU) stay. The cuff leak test (CLT) is commonly used to predict postextubation stridor and reintubation risk, but its clinical utility remains controversial. This study evaluated the relationship between CLT results and reintubation risk in a large cohort of critically ill patients.

METHODS: This single-center, retrospective, descriptive study analyzed 742 adult patients admitted to the medical and surgical ICUs who underwent mechanical ventilation for ≥24 h between January 2020 and December 2024. The primary outcome was reintubation within 48 h of planned extubation. Quantitative cuff leak volume measurements were performed preextubation, with leak volume expressed as absolute values and percentage of tidal volume. Multivariable logistic regression was used to identify independent predictors of reintubation, including CLT results and patient characteristics.

RESULTS: Of the 742 patients studied, 68 (9.2%) required reintubation within 48 h. Patients with a cuff leak volume <110 mL or <15% of tidal volume had significantly higher reintubation rates (18.7% vs. 7.1%, P < 0.001). After adjusting for confounding variables, a positive CLT (defined as cuff leak volume <110 mL) remained independently associated with reintubation (adjusted odds ratio, 2.86; 95% confidence interval [CI], 1.65-4.97; P < 0.001). Other significant independent predictors included prolonged intubation (>7 days), female sex, body mass index >30 kg/m 2 , and traumatic or difficult intubation. Combining CLT results with these clinical risk factors improved prediction accuracy (area under the curve, 0.82; 95% CI, 0.76-0.87).

CONCLUSION: A positive CLT is independently associated with increased reintubation risk in critically ill patients. The predictive accuracy is enhanced when CLT results are combined with clinical risk factors. These findings suggest that CLT should be incorporated into extubation decision-making, particularly for patients with additional risk factors for postextubation airway complications.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cao J, Liu Q, Wang Z, et al. Association Between Cuff Leak Test Results and Reintubation Risk: A Retrospective Analysis. Shock. 2025. PMID: 40705394. doi:10.1097/SHK.0000000000002674

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。